JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by O'Donnell, V. B.
Right arrow Articles by Freeman, B. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by O'Donnell, V. B.
Right arrow Articles by Freeman, B. A.

J Biol Chem, Vol. 274, Issue 29, 20083-20091, July 16, 1999

15-Lipoxygenase Catalytically Consumes Nitric Oxide and Impairs Activation of Guanylate Cyclase

Valerie B. O'DonnellDagger §, Kenneth B. Taylor, Sampath Parthasarathyparallel , Hartmut Kühn**, Doris KoeslingDagger Dagger , Andreas FriebeDagger Dagger , Allison BloodsworthDagger §, Victor M. Darley-Usmar§§§, and Bruce A. FreemanDagger §

From the Departments of Dagger  Anesthesiology,  Biochemistry and Molecular Genetics, and §§ Pathology and the § Center for Free Radical Biology, University of Alabama at Birmingham, Birmingham, Alabama 35233, the parallel  Department of Obstetrics and Gynecology, Emory University, Atlanta, Georgia 30322, the ** Institute of Biochemistry, Humboldt University, Hessische Strasse 3-4 Berlin, Germany, and the Dagger Dagger  Institute of Pharmacology, Freie University, Thielalle 69-73 Berlin, Germany

Analysis of purified soybean and rabbit reticulocyte 15-lipoxygenase (15-LOX) and PA317 cells transfected with human 15-LOX revealed a rapid rate of linoleate-dependent nitric oxide (·NO) uptake that coincided with reversible inhibition of product ((13S)-hydroperoxyoctadecadienoic acid, or (13S)-HPODE) formation. No reaction of ·NO (up to 2 µM) with either native (Ered) or ferric LOXs (0.2 µM) metal centers to form nitrosyl complexes occurred at these ·NO concentrations. During HPODE-dependent activation of 15-LOX, there was consumption of 2 mol of ·NO/mol of 15-LOX. Stopped flow fluorescence spectroscopy showed that ·NO (2.2 µM) did not alter the rate or extent of (13S)-HPODE-induced tryptophan fluorescence quenching associated with 15-LOX activation. Additionally, ·NO does not inhibit the anaerobic peroxidase activity of 15-LOX, inferring that the inhibitory actions of ·NO are due to reaction with the enzyme-bound lipid peroxyl radical, rather than impairment of (13S)-HPODE-dependent enzyme activation. From this, a mechanism of 15-LOX inhibition by ·NO is proposed whereby reaction of ·NO with EredLOO· generates Ered and LOONO, which hydrolyzes to (13S)-HPODE and nitrite (NO2-). Reactivation of Ered, considerably slower than dioxygenase activity, is then required to complete the catalytic cycle and leads to a net inhibition of rates of (13S)-HPODE formation. This reaction of ·NO with 15-LOX inhibited ·NO-dependent activation of soluble guanylate cyclase and consequent cGMP production. Since accelerated ·NO production, enhanced 15-LOX gene expression, and 15-LOX product formation occurs in diverse inflammatory conditions, these observations indicate that reactions of ·NO with lipoxygenase peroxyl radical intermediates will result in modulation of both ·NO bioavailability and rates of production of lipid signaling mediators.


Copyright © 1999 by The American Society for Biochemistry and Molecular Biology, Inc.



This article has been cited by other articles:


Home page
Circ. Res.Home page
H. Viita, J. Markkanen, E. Eriksson, M. Nurminen, K. Kinnunen, M. Babu, T. Heikura, S. Turpeinen, S. Laidinen, T. Takalo, et al.
15-Lipoxygenase-1 Prevents Vascular Endothelial Growth Factor A- and Placental Growth Factor-Induced Angiogenic Effects in Rabbit Skeletal Muscles via Reduction in Growth Factor mRNA Levels, NO Bioactivity, and Downregulation of VEGF Receptor 2 Expression
Circ. Res., February 1, 2008; 102(2): 177 - 184.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
C. N. Hall and J. Garthwaite
Inactivation of nitric oxide by rat cerebellar slices
J. Physiol., December 1, 2006; 577(2): 549 - 567.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
P. C. Williams, M. J. Coffey, B. Coles, S. Sanchez, J. D. Morrow, J. R. Cockcroft, M. J. Lewis, and V. B. O'Donnell
In vivo aspirin supplementation inhibits nitric oxide consumption by human platelets
Blood, October 15, 2005; 106(8): 2737 - 2743.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
H. Gupta, C. R. White, S. Handattu, D. W. Garber, G. Datta, M. Chaddha, L. Dai, S. H. Gianturco, W. A. Bradley, and G.M. Anantharamaiah
Apolipoprotein E Mimetic Peptide Dramatically Lowers Plasma Cholesterol and Restores Endothelial Function in Watanabe Heritable Hyperlipidemic Rabbits
Circulation, June 14, 2005; 111(23): 3112 - 3118.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
F. J. Schopfer, P. R. S. Baker, G. Giles, P. Chumley, C. Batthyany, J. Crawford, R. P. Patel, N. Hogg, B. P. Branchaud, J. R. Lancaster Jr., et al.
Fatty Acid Transduction of Nitric Oxide Signaling: NITROLINOLEIC ACID IS A HYDROPHOBICALLY STABILIZED NITRIC OXIDE DONOR
J. Biol. Chem., May 13, 2005; 280(19): 19289 - 19297.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
P. B. Anning, B. Coles, A. Bermudez-Fajardo, P. E.M. Martin, B. S. Levison, S. L. Hazen, C. D. Funk, H. Kuhn, and V. B. O'Donnell
Elevated Endothelial Nitric Oxide Bioactivity and Resistance to Angiotensin-Dependent Hypertension in 12/15-Lipoxygenase Knockout Mice
Am. J. Pathol., March 1, 2005; 166(3): 653 - 662.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
D. G. Lim, S. Sweeney, A. Bloodsworth, C. R. White, P. H. Chumley, N. R. Krishna, F. Schopfer, V. B. O'Donnell, J. P. Eiserich, and B. A. Freeman
Nitrolinoleate, a nitric oxide-derived mediator of cell function: Synthesis, characterization, and vasomotor activity
PNAS, December 10, 2002; 99(25): 15941 - 15946.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. R. Clark, M. J. Coffey, R. M. Maclean, P. W. Collins, M. J. Lewis, A. R. Cross, and V. B. O'Donnell
Characterization of Nitric Oxide Consumption Pathways by Normal, Chronic Granulomatous Disease and Myeloperoxidase-Deficient Human Neutrophils
J. Immunol., November 15, 2002; 169(10): 5889 - 5896.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. J. Coffey, R. Natarajan, P. H. Chumley, B. Coles, P.-R. Thimmalapura, M. Nowell, H. Kuhn, M. J. Lewis, B. A. Freeman, and V. B. O'Donnell
Catalytic consumption of nitric oxide by 12/15- lipoxygenase: Inhibition of monocyte soluble guanylate cyclase activation
PNAS, June 20, 2001; (2001) 141136098.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
S. Shiva, P. S. Brookes, R. P. Patel, P. G. Anderson, and V. M. Darley-Usmar
Nitric oxide partitioning into mitochondrial membranes and the control of respiration at cytochrome c oxidase
PNAS, June 19, 2001; 98(13): 7212 - 7217.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
V. B. O’Donnell and B. A. Freeman
Interactions Between Nitric Oxide and Lipid Oxidation Pathways : Implications for Vascular Disease
Circ. Res., January 19, 2001; 88(1): 12 - 21.
[Abstract] [Full Text]


Home page
Cardiovasc ResHome page
D. Tomasian, J. F. Keaney Jr., and J. A. Vita
Antioxidants and the bioactivity of endothelium-derived nitric oxide
Cardiovasc Res, August 18, 2000; 47(3): 426 - 435.
[Full Text] [PDF]


Home page
Cardiovasc ResHome page
R. P. Patel, A.-L. Levonen, J. H. Crawford, and V. M. Darley-Usmar
Mechanisms of the pro- and anti-oxidant actions of nitric oxide in atherosclerosis
Cardiovasc Res, August 18, 2000; 47(3): 465 - 474.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
A. Bloodsworth, V. B. O'Donnell, and B. A. Freeman
Nitric Oxide Regulation of Free Radical- and Enzyme-Mediated Lipid and Lipoprotein Oxidation
Arterioscler. Thromb. Vasc. Biol., July 1, 2000; 20(7): 1707 - 1715.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. Rubbo, R. Radi, D. Anselmi, M. Kirk, S. Barnes, J. Butler, J. P. Eiserich, and B. A. Freeman
Nitric Oxide Reaction with Lipid Peroxyl Radicals Spares alpha -Tocopherol during Lipid Peroxidation. GREATER OXIDANT PROTECTION FROM THE PAIR NITRIC OXIDE/alpha -TOCOPHEROL THAN alpha -TOCOPHEROL/ASCORBATE
J. Biol. Chem., April 6, 2000; 275(15): 10812 - 10818.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
V. B. O'Donnell, B. Coles, M. J. Lewis, B. C. Crews, L. J. Marnett, and B. A. Freeman
Catalytic Consumption of Nitric Oxide by Prostaglandin H Synthase-1 Regulates Platelet Function
J. Biol. Chem., December 1, 2000; 275(49): 38239 - 38244.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. M. Abu-Soud and S. L. Hazen
Nitric Oxide Is a Physiological Substrate for Mammalian Peroxidases
J. Biol. Chem., November 22, 2000; 275(48): 37524 - 37532.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. J. Coffey, R. Natarajan, P. H. Chumley, B. Coles, P.-R. Thimmalapura, M. Nowell, H. Kuhn, M. J. Lewis, B. A. Freeman, and V. B. O'Donnell
Catalytic consumption of nitric oxide by 12/15- lipoxygenase: Inhibition of monocyte soluble guanylate cyclase activation
PNAS, July 3, 2001; 98(14): 8006 - 8011.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 1999 by the American Society for Biochemistry and Molecular Biology.